Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pregnancy Hypertens ; 6(1): 30-7, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26955769

ABSTRACT

The bradykinin type 2 receptor (B2R), main effector of the pleiotropic kallikrein-kinin system (KKS), has been localized in the key sites related to placentation in human, rat and guinea pig utero-placental units. The present study was directed to characterize the content, the cellular and subcellular localization of B2R in the villi and basal plate of placentas from normal and preeclamptic pregnancies by means of western blotting, immunohistochemistry and immunoelectron microscopy. The protein content of B2R was demonstrated in both placental zones. The villous placenta of normal and preeclamptic pregnancies expressed B2R in syncytiotrophoblast and fetal endothelium; the basal plate displayed B2R in extravillous trophoblasts and decidual cells. Lastly, immunogold electron microscopy revealed B2R in fetal endothelium, syncytiotrophoblast, extravillous cytotrophoblasts and decidual cells; in all cell types the receptor was mainly located in the cytosol and nucleus. The protein content of placental homogenates and the immunoreactivity in the different cells types did not differ between both study groups; however the abundance of nuclear immunogold B2R positive beads in extravillous trophoblasts was greater in the normal than in the preeclamptic placentas. The purpose of describing nuclear B2R in the utero-placental unit, and its increment in normal extravillous trophoblasts, is to stimulate the study of the functional pathways that may be relevant to understand the local role of the B2R in normal and preeclamptic gestation.


Subject(s)
Cell Nucleus/chemistry , Placenta/chemistry , Pre-Eclampsia/metabolism , Receptor, Bradykinin B2/analysis , Uterus/chemistry , Adult , Biomarkers/analysis , Blotting, Western , Case-Control Studies , Cell Nucleus/ultrastructure , Chorionic Villi/chemistry , Decidua/chemistry , Endothelial Cells/chemistry , Female , Humans , Immunohistochemistry , Microscopy, Electron , Placenta/ultrastructure , Pre-Eclampsia/diagnosis , Pregnancy , Trophoblasts/chemistry , Uterus/ultrastructure , Young Adult
2.
Endocrine ; 29(3): 491-9, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16943589

ABSTRACT

In an effort to define the varied expression of three vasoactive markers in the clinical models of normal placenta/ normal invasion (n = 11), preeclampsia/restricted trophoblast invasion (n = 15), and placenta accreta/exaggerated invasion (n = 6), we performed semiquantitative immunohistochemistry for kallikrein, bradykinin B2 receptor, and endothelial nitric oxide synthase (eNOS). In the floating villi, the syncytiotrophoblast expressed more kallikrein in placenta accreta (p < 0.05), than in normal and preeclamptic placentas, while the bradykinin B2 receptor and eNOS were similarly expressed in all groups; in the fetal endothelium, the bradykinin B2 receptor was enhanced in placenta accreta (p < 0.005), but kallikrein and eNOS were similarly expressed in the other two groups. In the extravillous trophoblast, both kallikrein and eNOS expression were higher in placenta accreta (p < 0.001), while the bradykinin B2 receptor signal was only enhanced in preeclampsia (p < 0.05). The presence and localization of kallikrein, the bradykinin B2 receptor, and eNOS in the fetomaternal interface in the three study conditions supports a local role for interrelated vasodilatory/antiaggregating systems. This first report of the variations observed in kallikrein and eNOS in a condition of exaggerated trophoblast invasion supports the participation of vasodilatation in trophoblast migration.


Subject(s)
Kallikreins/metabolism , Nitric Oxide Synthase Type III/metabolism , Placenta Accreta/metabolism , Placenta/metabolism , Pre-Eclampsia/metabolism , Receptor, Bradykinin B2/metabolism , Chorionic Villi/metabolism , Endothelial Cells/metabolism , Female , Fetus/metabolism , Gene Expression , Gestational Age , Humans , Kallikreins/urine , Maternal-Fetal Exchange , Models, Biological , Placenta/blood supply , Pregnancy , Pregnancy Complications, Hematologic/metabolism , Pregnancy Outcome , Trophoblasts/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...